As an upstream activator of MEK-ERK signaling, RAC1 has also been implicated in pathological cardiac hypertrophy and activated by DEF6 in the immune system and cell morphology modification [7, 30, 31]. This evidence concerns the gene MAP2K7 and cardiac hypertrophy.